Alzamend Neuro, Inc. Share Price
NASDAQ: ALZN | Micro CapAlzamend Neuro, Inc. Stock Performance
Open $1.38 | Prev. Close $1.33 | Circuit Range N/A |
Day Range $1.38 - $1.38 | Year Range $0.88 - $2.63 | Volume 100 |
Average Traded $1.38 |
Alzamend Neuro, Inc. Share Price Today
As of 10 August 2026, Alzamend Neuro, Inc.'s share price is $1.38. The stock opened at $1.38, compared to its previous close of $1.33. During today's trading session, Alzamend Neuro, Inc.'s share price traded between $1.38 and $1.38, with an average price of $1.38. Over the past 52 weeks, the stock has recorded a high of $2.63 and a low of $0.88. In terms of performance, Alzamend Neuro, Inc.'s share price has declined by 30.30% over the last six months and is down 43.67% on a year-on-year basis.
Alzamend Neuro, Inc. Share Price Chart
Alzamend Neuro, Inc. Stock Fundamentals & Key Indicators
Market Cap $622102.62 | PE Ratio (TTM) -0.12 | Dividend Yield 18.84% |
EPS (TTM) $-11.32 | Revenue (TTM) -$14.87M | Return On Equity (TTM) -113.78% |
Profit Margin 30.36% | Debt to Equity 0.16 | Quarterly Earnings Growth YoY -111.56% |
Alzamend Neuro, Inc. Quarterly Profit & Loss
All figures in USD
Alzamend Neuro, Inc. Annual Profit & Loss
All figures in USD
About Alzamend Neuro, Inc.
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Alzamend Neuro, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.33 | $1.38 | +8.66% |
Jul 2026 | $1.30 | $1.27 | +1.60% |
Jun 2026 | $1.22 | $1.25 | +5.93% |
May 2026 | $1.05 | $1.18 | +9.77% |
Apr 2026 | $1.02 | $1.07 | +0.47% |
Mar 2026 | $1.96 | $1.07 | -45.96% |
Feb 2026 | $2.19 | $1.98 | -6.60% |
Jan 2026 | $1.97 | $2.12 | +21.14% |
Dec 2025 | $2.16 | $1.75 | -17.45% |
Nov 2025 | $2.44 | $2.12 | -18.46% |
Oct 2025 | $2.37 | $2.60 | +9.24% |
Sep 2025 | $2.39 | $2.38 | -2.86% |
ALZN Share Price FAQs
What is Alzamend Neuro, Inc. share price today?
What is the 52 week high and 52 week low of Alzamend Neuro, Inc. stock?
What is ALZN's market capitalisation today?
What is ALZN's net income for the last quarter?
What is the 5 year returns of ALZN?
What is the high & low stock price of ALZN today?
Can I buy ALZN shares in India?